From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2022 - Wiley Online Library
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

[PDF][PDF] From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

U Kozlowska, C Nichols, K Wiatr, M Figiel - unlimitedsciences.org
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2022 - search.ebscohost.com
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2021 - europepmc.org
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

From Psychiatry To Neurology: Psychedelics As Prospective Therapeutics For Neurodegenerative Disorders

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2022 - digitalscholar.lsuhsc.edu
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …